Trevi Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| NEA MANAGEMENT COMPANY, LLC | 11/14/2024 | 11.37 M | $37.98 M | 0.00% | 11.25% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/15/2024 | 7.38 M | $24.65 M | 0.00% | 7.31% |
| RUBRIC CAPITAL MANAGEMENT LP | 11/13/2024 | 5.03 M | $16.79 M | 0.00% | 4.98% |
| VIKING GLOBAL INVESTORS LP | 11/14/2024 | 4.40 M | $14.70 M | 0.00% | 4.35% |
| VR ADVISER, LLC | 11/14/2024 | 3.42 M | $11.43 M | 0.00% | 3.39% |
| VANGUARD GROUP INC | 11/13/2024 | 3.26 M | $10.90 M | 33.84% | 3.23% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 3.22 M | $10.76 M | 100.00% | 3.19% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2024 | 2.75 M | $9.19 M | -1.79% | 2.72% |
| OPALEYE MANAGEMENT INC. | 11/14/2024 | 2.57 M | $8.58 M | -2.91% | 2.54% |
| VIVO CAPITAL, LLC | 11/13/2024 | 1.61 M | $5.39 M | 100.00% | 1.60% |
| BIOIMPACT CAPITAL LLC | 11/13/2024 | 1.54 M | $5.14 M | 1.88% | 1.52% |
| MAI CAPITAL MANAGEMENT | 11/07/2024 | 1.33 M | $4.43 M | 0.67% | 1.31% |
| ALLY BRIDGE GROUP (NY) LLC | 11/14/2024 | 1.32 M | $4.42 M | -10.31% | 1.31% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.26 M | $4.22 M | 10.24% | 1.25% |
| STATE STREET CORP | 11/14/2024 | 952,912 | $3.18 M | 5.90% | 0.94% |
| ROSALIND ADVISORS, INC. | 10/30/2024 | 750,000 | $2.51 M | -46.10% | 0.74% |
| WOODLINE PARTNERS LP | 11/14/2024 | 606,227 | $2.02 M | 100.00% | 0.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/14/2024 | 482,575 | $1.61 M | -42.84% | 0.48% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 11/08/2024 | 424,725 | $1.42 M | -29.85% | 0.42% |
| ACUTA CAPITAL PARTNERS, LLC | 11/14/2024 | 290,500 | $970,270 | 11.73% | 0.29% |
| CHECKPOINT CAPITAL L.P. | 11/14/2024 | 250,000 | $835,000 | -50.01% | 0.25% |
| TEJARA CAPITAL LTD | 11/13/2024 | 241,613 | $806,987 | -40.49% | 0.24% |
| MORGAN STANLEY | 11/14/2024 | 198,480 | $662,922 | 123.06% | 0.20% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 185,481 | $619,507 | 0.00% | 0.18% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 164,238 | $548,555 | 124.39% | 0.16% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 150,918 | $504,066 | 0.00% | 0.15% |
| J. GOLDMAN & CO LP | 11/14/2024 | 148,917 | $497,383 | 0.00% | 0.15% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 137,284 | $458,529 | -23.09% | 0.14% |
| J. GOLDMAN & CO LP | 11/14/2024 | 123,200 | $411,488 | 100.00% | 0.12% |
| GSA CAPITAL PARTNERS LLP | 11/05/2024 | 122,447 | $409,000 | 100.00% | 0.12% |
| JPMORGAN CHASE & CO | 11/08/2024 | 100,517 | $335,727 | 220.63% | 0.10% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 96,350 | $321,809 | 0.00% | 0.10% |
| RAYMOND JAMES & ASSOCIATES | 10/18/2024 | 95,383 | $318,579 | 853.83% | 0.09% |
| BARCLAYS PLC | 11/19/2024 | 95,232 | $319,000 | 180.80% | 0.09% |
| SHAY CAPITAL LLC | 11/14/2024 | 93,962 | $313,833 | 6.22% | 0.09% |
| RHUMBLINE ADVISERS | 11/12/2024 | 81,971 | $273,773 | 8.98% | 0.08% |
| OPPENHEIMER & CO INC | 11/05/2024 | 81,947 | $273,703 | 34.74% | 0.08% |
| MARSHALL WACE, LLP | 11/14/2024 | 81,124 | $270,954 | 100.00% | 0.08% |
| PFS PARTNERS, LLC | 11/01/2024 | 79,000 | $263,860 | 0.00% | 0.08% |
| FRED ALGER MANAGEMENT, LLC | 11/14/2024 | 76,544 | $255,657 | 100.00% | 0.08% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 72,210 | $241,133 | 0.00% | 0.07% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 70,700 | $236,138 | 36.22% | 0.07% |
| WEALTHTRUST AXIOM LLC | 11/13/2024 | 63,500 | $212,090 | 0.00% | 0.06% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 53,990 | $180,327 | -0.22% | 0.05% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 11/13/2024 | 50,000 | $167,000 | 100.00% | 0.05% |
| CITADEL ADVISORS LLC | 11/14/2024 | 49,881 | $166,603 | 100.00% | 0.05% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 47,747 | $159,475 | 7.82% | 0.05% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 40,378 | $134,862 | 100.00% | 0.04% |
| TRUST CO OF TOLEDO NA /OH/ | 10/02/2024 | 36,502 | $121,917 | 0.00% | 0.04% |
| LPL FINANCIAL LLC | 11/08/2024 | 36,000 | $120,240 | 0.00% | 0.04% |
Trevi Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 90 institutional investors and hedge funds held shares of Trevi Therapeutics, Inc.. The most heavily invested institutionals were:
NEA Management Company, LLC: 11.37 M
Frazier Life Sciences Management, L.P.: 7.38 M
Rubric Capital Management LP: 5.03 M
VIKING GLOBAL INVESTORS LP: 4.4 M
VR Adviser, LLC: 3.42 M
VANGUARD GROUP INC: 3.26 M
57.52% of Trevi Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 65.51 M shares in the last 24 months. This purchase volume represents approximately $262.03 M in transactions.